Mainstreaming genomic testing for mitochondrial disease in Australia.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  European Journal of Human Genetics

• Publication date

  2026-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41431-026-02053-6PMID 41748927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Opportunities and challenges for paediatricians requesting funded genomic tests for children

  2025cited by this paper
• Determining the value of genomics in healthcare

  2025cited by this paper
• Genomic Testing in Australia: A Budget Impact Analysis Using Diffusion Modelling from a Healthcare System Perspective.

  2025cited by this paper
• Evaluating genome sequencing strategies: trio, singleton, and standard testing in rare disease diagnosis

  2025cited by this paper
• Genomic sequencing technologies for rare disease in mainstream healthcare: the current state of implementation

  2025cited by this paper
• Mainstreaming of clinical genetic testing: a conceptual framework.

  2025cited by this paper
• Non-geneticist champions are essential to the mainstreaming of genomic medicine

  2025cited by this paper
• Utilisation of subsidised genetic and genomic testing in a publicly funded healthcare system 2014–2023

  2025cited by this paper
• Review: Utility of mass spectrometry in rare disease research and diagnosis

  2025cited by this paper
• Critically unwell infants and children with mitochondrial disorders diagnosed by ultra-rapid genomic sequencing.

  2024cited by this paper
• Mitochondrial disorder diagnosis and management- what the pediatric neurologist wants to know.

  2024cited by this paper
• Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders

  2024cited by this paper
• Implementation of reimbursement for genomic testing in Australia: early successes and the pathway ahead

  2024cited by this paper
• Genomic multidisciplinary teams: A model for navigating genetic mainstreaming and precision medicine

  2024cited by this paper
• Ending an Odyssey? The Psychosocial Experiences of Parents after the Genetic Diagnosis of a Mitochondrial Disease in Children

  2024cited by this paper
• Assessing the unmet needs of genomic testing in Australia: a geospatial exploration

  2024cited by this paper
• Ensuring best practice in genomics education: A theory- and empirically informed evaluation framework

  2024cited by this paper
• Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access

  2024cited by this paper
• The evolution of the mitochondrial disease diagnostic odyssey

  2023cited by this paper
• Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia

  2023cited by this paper
• The Australian Genomics Mitochondrial Flagship: A National Program Delivering Mitochondrial Diagnoses

  2023cited by this paper
• Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare.

  2023cited by this paper
• Integrated multi-omics for rapid rare disease diagnosis on a national scale

  2023cited by this paper
• Mainstreaming proteomics into rare disease diagnostics

  2022cited by this paper
• Specialist multidisciplinary input maximises rare disease diagnoses from whole genome sequencing

  2022cited by this paper
• Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines

  2022cited by this paper
• Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study

  2021cited by this paper
• A dynamic systems view of clinical genomics: a rich picture of the landscape in Australia using a complexity science lens

  2021cited by this paper
• Measuring physician practice, preparedness and preferences for genomic medicine: a national survey

  2021cited by this paper
• Specifications of the ACMG/AMP standards and guidelines for mitochondrial DNA variant interpretation

  2020cited by this paper
• MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations

  2020cited by this paper
• The diagnostic utility of genome sequencing in a pediatric cohort with suspected mitochondrial disease

  2020cited by this paper
• Genetics of mitochondrial diseases: Identifying mutations to help diagnosis

  2020cited by this paper
• mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease

  2018cited by this paper
• Genetic diagnosis of Mendelian disorders via RNA sequencing

  2017cited by this paper
• Mitochondrial diseases

  2016cited by this paper
• KBG Syndrome: A Case Report and Longitudinal Assessment of Long‐Acting Recombinant Human Growth Hormone Therapy

  2015cited by this paper
• Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support

  2009cited by this paper
• The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease.

  2008cited by this paper
• Clinical spectrum and diagnosis of mitochondrial disorders.

  2001cited by this paper

• No citing papers are available for this paper.